Sign in

CIK 0001178253

  • Non-accelerated filer
  • Smaller reporting company

SCYNEXIS INC

Sign in to watch
Ticker
SCYX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
562181648
Phone
+1 201-884-5485
Business address
1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2014-05-07 Arthaud Laurent Director Option exercise · Common Stock Warrant (right to buy) −34 0
2014-05-07 Arthaud Laurent Director Option exercise · Common Stock Warrant (right to buy) −222 0
2014-05-07 Arthaud Laurent Director Conversion · Series D-1 Preferred Stock −8,127 0
2014-05-07 Arthaud Laurent Director Conversion · Series D-2 Preferred Stock −1,665 0
2014-05-07 FCPR Biotechnology Fund 10% owner Option exercise +5,251 $0.20 $1K 5,251
2014-05-07 FCPR Biotechnology Fund 10% owner Option exercise +5,251 $0.20 $1K 10,502
2014-05-07 FCPR Biotechnology Fund 10% owner Option exercise +25,998 $0.20 $5K 36,500
2014-05-07 FCPR Biotechnology Fund 10% owner Conversion +46,863 83,363
2014-05-07 FCPR Biotechnology Fund 10% owner Conversion +88,796 172,159
2014-05-07 FCPR Biotechnology Fund 10% owner Conversion +42,336 214,495
2014-05-07 FCPR Biotechnology Fund 10% owner Conversion +30,582 245,077
2014-05-07 FCPR Biotechnology Fund 10% owner Purchase +50,000 $10.00 $500K 295,077
2014-05-07 FCPR Biotechnology Fund 10% owner Option exercise · Common Stock Warrant (right to buy) −5,251 0
2014-05-07 FCPR Biotechnology Fund 10% owner Option exercise · Common Stock Warrant (right to buy) −5,251 0
2014-05-07 FCPR Biotechnology Fund 10% owner Option exercise · Common Stock Warrant (right to buy) −25,998 0
2014-05-07 FCPR Biotechnology Fund 10% owner Conversion · Series B Preferred Stock −166,482 0
2014-05-07 FCPR Biotechnology Fund 10% owner Conversion · Series C Preferred Stock −313,996 0
2014-05-07 FCPR Biotechnology Fund 10% owner Conversion · Series D-1 Preferred Stock −863,672 0
2014-05-07 FCPR Biotechnology Fund 10% owner Conversion · Series D-2 Preferred Stock −623,880 0
2014-05-07 Nothias Jean-Yves Director Option exercise +5,251 $0.20 $1K 5,251

Page 22 of 26 · 507 trades